Mar 2, 2026 06:10AM
Mar 2, 2026 06:01AM
Mar 2, 2026 06:01AM
Feb 11, 2026 07:00AM
Dec 12, 2025 10:47AM
Dec 4, 2025 07:10AM
Dec 4, 2025 07:02AM Denali Therapeutics secures $275 million royalty deal with Royalty Pharma
Dec 4, 2025 07:00AM
Nov 5, 2025 07:00AM
Nov 4, 2025 07:15AM
Nov 4, 2025 07:15AM
Sep 11, 2025 07:00AM
Sep 2, 2025 07:15AM
Sep 2, 2025 07:15AM Royalty Pharma and Zenas BioPharma Enter Into Obexelimab Funding Agreement for Up to $300 Million
Sep 2, 2025 07:05AM
Aug 25, 2025 06:10AM
Aug 25, 2025 06:10AM
Aug 25, 2025 06:10AM
Aug 25, 2025 06:01AM
Aug 25, 2025 06:00AM
Aug 6, 2025 07:00AM Royalty Pharma Reports Second Quarter 2025 Results
Jul 17, 2025 08:15AM
Jul 17, 2025 08:15AM
May 16, 2025 04:30PM
May 16, 2025 06:12AM
May 12, 2025 04:17PM
May 12, 2025 04:15PM
May 12, 2025 04:15PM Royalty Pharma Announces Shareholder Approval of its External Manager Acquisition
May 12, 2025 04:15PM
May 8, 2025 07:15AM
Feb 11, 2025 07:15AM
Jan 29, 2025 09:04AM
Jan 29, 2025 09:00AM
Jan 10, 2025 07:30AM
Jan 10, 2025 07:16AM Royalty Pharma (RPRX) Announces Acquisition of its External Manager and $3 Billion Share Repurchase Program
Jan 10, 2025 07:15AM
Nov 7, 2024 07:11AM
Nov 7, 2024 07:10AM
Nov 6, 2024 07:15AM
Oct 7, 2024 09:28AM
Aug 8, 2024 07:00AM
May 28, 2024 07:10AM Royalty Pharma plc (RPRX) and Agios Pharmaceuticals (AGIO) Enter Into Vorasidenib Royalty Agreement for $905 Million
May 28, 2024 07:10AM
May 9, 2024 07:00AM
May 9, 2024 06:45AM
May 9, 2024 06:45AM
Feb 15, 2024 07:30AM
Jan 8, 2024 07:00AM
Nov 8, 2023 07:00AM Royalty Pharma Reports Third Quarter 2023 Results
Oct 19, 2023 08:00AM

1,155,245 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All